Marissa F. Dockendorf

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients

Matthew Kennedy, Andrew W. Stamford, Xia Chen et al. · Science Translational Medicine · 2016 · 407 citations

Glucose Homeostasis, Bace1 Inhibitor Verubecestat, Enzyme 1 +20

Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers

Michael Neely, Hasan S. Jafri, Nita L. Seibel et al. · Antimicrobial Agents and Chemotherapy · 2008 · 79 citations · Full text

Drug Safety, Bioanalysis, Pharmacology +11

Safety, Tolerability and Pharmacokinetics of Doravirine, a Novel HIV Non-Nucleoside Reverse Transcriptase Inhibitor, after Single and Multiple doses in Healthy Subjects

Matt S. Anderson, Jocelyn Gilmartin, Caroline Cilissen et al. · Antiviral Therapy · 2014 · 77 citations · Full text

An Integrated Strategy for Implementation of Dried Blood Spots in Clinical Development Programs

Prajakti A. Kothare, Kevin P. Bateman, Marissa F. Dockendorf et al. · The AAPS Journal · 2016 · 52 citations · Full text

Healthy Subjects, Translational Medicine, Alzheimer's Disease +20

Facial and Vocal Markers of Schizophrenia Measured Using Remote Smartphone Assessments: Observational Study

Anzar Abbas, Bryan J. Hansen, Vidya Koesmahargyo et al. · JMIR Formative Research · 2021 · 50 citations · Full text